Loại tài liệu:    Chỉ tìm trong: 
41-50 trong số 57 kết quả
Adverse Events Associated with Inclisiran: A Real-world pharmacovigilance study of FDA adverse event reporting system (F...
Tác giả: Bing Li, Yan Chen, Yongyi Zhang, Mengying Qian, Qing Shan, Jiao Qian, Jinmin Guo
Xuất bản: England: Expert opinion on drug safety , 2025
Bộ sưu tập: NCBI
ddc:  940.454
 
Assessing adverse event burden in chronic lymphocytic leukemia treatment regimens: what's best for patient quality of li...
Tác giả: Anna Korycka-Wołowiec, Dariusz Wołowiec, Hanna Ławnicka, Tadeusz Robak
Xuất bản: England: Expert opinion on drug safety , 2025
Bộ sưu tập: NCBI
ddc:  616.99419
 
Comparative analysis of CDKI-related adverse events in older patients: a real-world data from the FDA adverse event repo...
Tác giả: Qiongtong Fang, Yishen Chen, Fuqiang Huang, Jiabi Liang, Wenji Luo, Xinrong Wu, Meirong Zhang, Huibin Zhao
Xuất bản: England: Expert opinion on drug safety , 2025
Bộ sưu tập: NCBI
ddc: 
 
Mining and analysis of amphotericin B adverse reaction signals: a real-world study based on the FAERS database
Tác giả: Siqi Wang, Yimei Cheng, Xing Wang, Qian Wang
Xuất bản: England: Expert opinion on drug safety , 2025
Bộ sưu tập: NCBI
ddc:  171.8
 
Rivaroxaban to reduce the risk of major cardiovascular events in patients with chronic coronary artery disease or periph...
Tác giả: Toufik Abdul-Rahman, Poulami Roy, Ahmed Altibi, Rahul Gupta, Ranferi Eduardo Herrera-Calderón, Jann Ludwig Mueller-Gomez, Marcos Lisbona-Buzali, Sebahat Ulusan, Wireko Andrew Awuah, Nataliia Kuchma, Nikhil Mehta, Ankit Agrawal
Xuất bản: England: Expert opinion on drug safety , 2025
Bộ sưu tập: NCBI
ddc:  616.851
 
Hospital-wide interventions for reducing or preventing in-hospital prescribing errors: a scoping review
Tác giả: Rashudy Fatiha Mahomedradja, Steven Wang, Kim Catherina Eve Sigaloff, Jelle Tichelaar, Michiel Adriaan van Agtmael
Xuất bản: England: Expert opinion on drug safety , 2025
Bộ sưu tập: NCBI
ddc:  368.3827
 
The role of artificial intelligence in pharmacovigilance for rare diseases
Tác giả: Ashish Jain, Zahabia Adenwala
Xuất bản: England: Expert opinion on drug safety , 2025
Bộ sưu tập: NCBI
ddc: 
 
Risk of acute renal failure associated with combined use of SGLT2 inhibitors and potentially nephrotoxic drugs: an epide...
Tác giả: Ting Yu, Jian Xiao, Mengyao Li, Shu Qiao Cheng, Ruwen Cai, Ling Huang, Huimin Yu, Jing Yang Li, Ying-Ying Zhang, Ying Wang
Xuất bản: England: Expert opinion on drug safety , 2025
Bộ sưu tập: NCBI
ddc:  394.14
 
A comprehensive exploration of adverse reactions to lapatinib: a disproportionate analysis based on the FAERS database
Tác giả: Yao Zhou, Jie Gong, Xianguang Deng, Lele Shen, Anqi Ge, Hongqiao Fan, Jie Ling, Shiting Wu, Lifang Liu
Xuất bản: England: Expert opinion on drug safety , 2025
Bộ sưu tập: NCBI
ddc:  171.8
 
Impact of baseline glucocorticoids (GCs) on cardiotoxic events and myocardial damage related to immune checkpoint inhibi...
Tác giả: Qiaoyun Wang, Haixia Zhang, Yawen Chen, Xin Lv, Yanli Qiao, Qiaoling Zhu
Xuất bản: England: Expert opinion on drug safety , 2025
Bộ sưu tập: NCBI
ddc:  371.1007
 

Truy cập nhanh danh mục